Advanced Medical Solutions Group PLC

STU:AQA (UK)   Ordinary Shares
€ 2.08 (0%) Apr 18
24.55
P/B:
1.59
Market Cap:
€ 467.79M ($ 498.42M)
Enterprise V:
€ 408.24M ($ 434.97M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Advanced Medical Solutions Group PLC ( STU:AQA ) from 2016 to Apr 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Advanced Medical Solutions Group PLC stock (STU:AQA) PE ratio as of Apr 19 2024 is 24.55. More Details

Advanced Medical Solutions Group PLC (STU:AQA) PE Ratio (TTM) Chart

To

Advanced Medical Solutions Group PLC (STU:AQA) PE Ratio (TTM) Historical Data

Total 1212
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Advanced Medical Solutions Group PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-20 24.8 2024-02-14 28.1
2024-04-18 24.8 2024-02-13 27.9
2024-04-17 24.8 2024-02-12 28.3
2024-04-16 24.5 2024-02-09 28.3
2024-04-15 24.8 2024-02-08 28.3
2024-04-12 24.5 2024-02-07 27.9
2024-04-11 24.5 2024-02-06 28.3
2024-04-10 24.5 2024-02-05 28.1
2024-04-09 24.3 2024-02-02 29.1
2024-04-08 24.5 2024-02-01 28.6
2024-04-05 25.2 2024-01-31 27.9
2024-04-04 25.5 2024-01-30 28.3
2024-04-03 25.2 2024-01-29 28.6
2024-04-02 26.9 2024-01-26 28.3
2024-03-28 26.4 2024-01-25 27.9
2024-03-27 25.5 2024-01-24 28.1
2024-03-26 25.0 2024-01-23 28.3
2024-03-25 25.2 2024-01-22 28.1
2024-03-22 25.2 2024-01-19 27.4
2024-03-21 25.5 2024-01-18 28.1
2024-03-20 25.7 2024-01-17 27.6
2024-03-19 25.5 2024-01-16 28.3
2024-03-18 25.5 2024-01-12 28.8
2024-03-15 25.7 2024-01-11 28.6
2024-03-14 28.1 2024-01-10 28.6
2024-03-13 28.8 2024-01-09 27.1
2024-03-12 28.6 2024-01-08 27.1
2024-03-11 28.6 2024-01-05 27.6
2024-03-08 29.3 2024-01-04 27.4
2024-03-07 29.5 2024-01-03 26.9
2024-03-06 28.3 2024-01-02 27.9
2024-03-05 27.6 2023-12-29 28.1
2024-03-04 28.1 2023-12-28 28.1
2024-03-01 27.9 2023-12-27 22.9
2024-02-29 28.1 2023-12-22 22.9
2024-02-28 27.9 2023-12-21 22.9
2024-02-27 28.1 2023-12-20 23.3
2024-02-26 28.3 2023-12-19 23.3
2024-02-23 28.6 2023-12-18 22.9
2024-02-22 28.3 2023-12-15 23.3
2024-02-21 28.1 2023-12-14 23.1
2024-02-20 28.1 2023-12-13 22.1
2024-02-19 28.3 2023-12-12 22.1
2024-02-16 27.9 2023-12-11 21.9
2024-02-15 27.6 2023-12-08 21.9

Advanced Medical Solutions Group PLC (STU:AQA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Advanced Medical Solutions Group PLC
NAICS : 339113
ISIN : GB0004536594

Share Class Description:

STU:AQA: Ordinary Shares
Description
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.